Biogen Inc.

NasdaqGS:BIIB

Sector

🏥 Health Care

Industries

🔬 Clinical Trials

🧬 Biotechnology

💊 Pharmaceuticals

Location

United States

Market Cap

USD 18.94 B

Share Price

USD 129.28

Avg Daily Volume

1,561,840

Change (1 day)

-1.70%

Change (1 year)

-38.78%

Change (YTD)

-15.46%

Biogen Inc. EBIT for the Trailing 12 Months (TTM) ending March 31, 2025: USD 1.99 B

Biogen Inc. EBIT is USD 1.99 B for the Trailing 12 Months (TTM) ending March 31, 2025, a 28.53% change year over year. EBIT means earnings before interest and taxes, it is calculated as operating income plus non-operating income.

Biogen Inc. EBIT for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 1.55 B, a -45.38% change year over year.
Biogen Inc. EBIT for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 2.84 B, a 42.32% change year over year.
Biogen Inc. EBIT for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 2.00 B, a -54.73% change year over year.
Biogen Inc. EBIT for the Trailing 12 Months (TTM) ending March 31, 2021 was USD 4.41 B, a -39.59% change year over year.